Dr. Christoph Stähli is a senior scientist with a strong background in materials science, analytical chemistry and cell biology. He earned his B.Sc. (2007) and M.Sc. (2009) from the Swiss Federal Institute of Technology Lausanne (EPFL), where he completed his Master’s thesis on the tribo­corrosion resistance of bio­medical CoCrMo alloys. In 2014, he obtained his Ph.D. from McGill University, Montreal, Canada, where his research focused on the stimulation of angio­genesis (growth of blood vessels) through copper ion release from bio­active glasses. In 2018, he obtained a CAS in Management of Biotech, Medtech & Pharma Ventures from EPFL.

Since joining RMS Foundation in 2015, he has been providing materials testing and consulting services, along­side conducting research in the field of synthetic calcium phos­phate-based bone substitute materials. Positioned at the inter­face of industry and fundamental research, he has developed new analytical methods specifically tailored to meet regulatory require­ments of medical device man­u­fac­tu­rers. His work has placed particular emphasis on trace element analysis using inductively coupled plasma-mass spectro­metry (ICP-MS) and in vitro dissolution testing. His research has aimed to deepen the under­standing of how crystalline phase structure, chemical composition, and processing parameters influence the physico­chemical properties of calcium phos­phate ceramics.